About the MIB

About the MIB

The Manchester Institute of Biotechnology brings together researchers from biology, chemistry and engineering to explore new scientific possibilities. Through collaborative projects and innovative technologies, we develop practical solutions to pressing global challenges and and work with international partners to translate discovery into real‑world impact. 

Discover more about the MIB

Our research themes

Looking for expertise in engineering biology?

Looking for expertise in engineering biology?

If you are an industrialist, policymaker, academic or simply someone who would like to know more about what we do, we welcome conversations about how our research can help you. 

Get in touch with us

News

Show previous news story Show next news story

Professor Neil Dixon appointed to UK Government’s DSIT College of Experts as Engineering Biology lead

Manchester researcher joins national network of leading specialists helping shape the future of UK science, innovation and industrial growth.

Manchester scientists design ‘tunable’ biomolecules to probe how sugars behave

Researchers at the Manchester Institute of Biotechnology have developed a new way to precisely build and modify complex sugar molecules, creating powerful tools to study how they function in biology and disease.

Researchers discover new way to control ice growth using polymer nanoparticles

Researchers at The Manchester Institute of Biotechnology have developed a new approach to designing materials that control how ice crystals grow, opening up new possibilities for cryobiology, food storage and anti‑icing technologies.

MIB researcher awarded BBSRC fellowship to advance carbon‑efficient biomanufacturing

Dr Micaela Chacón, a post-doctoral researcher at the Manchester Institute of Biotechnology (MIB) has been awarded a prestigious fellowship from the Biotechnology and Biological Sciences Research Council (BBSRC), supporting new work to improve the carbon efficiency of microbial manufacturing.

University of Manchester techbio spin-out secures £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next gen enzyme engineering

A Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone.

Our research impact

Our research is designed to have impact, and contributes to many of today’s advancements in health, nutrition, energy, environmental protection and transport.

Discover our impact

Bottle of "Tales from the future", lemon and rose, 5% abv, and a glass containing some of the drink

Join us

Whether you’re looking for a PhD opportunity or your next career move, we have opportunities for students, researchers, technical specialists and professional services to join our vibrant research community.

See where you can fit in

""